This article is more than 5 years old. Information may no longer be current.

On our way to Amsterdam: Breaking news and more from ESC Congress

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

For 5 days, Amsterdam will be the spot for the latest cutting-edge technologies and potentially transformative developments in the field of cardiology. With more than 30,000 attendees and 4,000 presentations, the European Society of Cardiology Congress, which will be taking place there from Aug. 31 to Sept. 4, will likely provide some of the most talked-about data for months to come.

Among the presentations planned are four Hot Line sessions featuring 20 major trials in thrombosis, coronary intervention and devices, diabetes, HF and ACS. These will include the Hokusai VTE study, which is the largest single-agent phase 3 trial on the treatment and prevention of recurrent venous thromboembolism; the phase 3 EXAMINE trial testing the CV safety of alogliptin in patients with type 2 diabetes and ACS; and the randomized TASTE trial assessing thrombus aspiration during STEMI.

 

Keith A. A. Fox

“It's a really exciting, diverse collection of Hot Lines with novel findings, new treatments and the potential to change practice in cardiology,” Keith A. A. Fox, MB, ChB, ESC Congress Program Committee Chairperson, said in a press release issued by ESC.

Cardiology Today and Cardiology Today’s Intervention will be onsite in Amsterdam throughout the congress. Stay tuned to Healio.com/Cardiology for the latest news and developments, along with videos, physician perspectives and more.